Kura Oncology Inc (KURA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO, CA 92130

Kura Oncology, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on discovery and development of personalized therapeutics for the treatment of tumors and blood cancers. Kura Oncology offers development programs for cancers with high unmet need, including lung, colorectal, thyroid, blood, and pancreatic cancers.

Data as of 2020-09-12
Market Cap1.541 Billion Shares Outstanding56.283 Million Avg 30-day Volume696.892 Thousand
P/E Ratio Dividend Yield EPS-1.58
Price/Sales Price cash flow ratio Price free cash flow ratio-24.4
Book Value5.73 Price to Tangible Book4.69 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.174742
BETA2.43123 52-week High/Low28.0 / 6.35 Stddev0.249018
View SEC Filings from KURA instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 6 4 50.0% 4 (0.26%) 2 (0.13%) 100.0%
Funds Holding: 134 120 11.67% 53 (3.46%) 44 (2.81%) 20.45%
13F shares: 52.271 Million 39.659 Million 31.8% 25.224 Million 18.688 Million 34.97%
% Ownership 92.8719 87.3013 6.38% 44.8157 41.1376 8.94%
New Positions: 31 13 138.46% 16 5 220.0%
Increased Positions 57 48 18.75% 16 23 -30.43%
Closed Positions 16 20 -20.0% 7 6 16.67%
Reduced Positions 35 41 -14.63% 18 15 20.0%
Total Calls 191.386 Thousand 36 531527.78% 167.7 Thousand
Total Puts 41.81 Thousand 12.623 Thousand 231.22% 16.5 Thousand 12 Thousand 37.5%
PUT/CALL Ratio 0.22 350.64 -99.94% 0.1 -99.97%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KURA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KURA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

362.4 Thousand total shares from 18 transactions

Exercise Derivative Conversion (M)

159.5 Thousand total shares from 15 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GRASSO MARC CFO, CBO

  • Officer
0 2020-09-14 5

FORD KATHLEEN CHIEF OPERATING OFFICER

  • Officer
0 2020-09-14 2

WILSON TROY EDWARD PRESIDENT AND CEO

  • Officer
  • Director
2,029,849 2020-09-11 6

DALE STEPHEN CHIEF MEDICAL OFFICER

  • Officer
0 2020-08-24 2

HOFFMAN ROBERT

  • Director
0 2020-06-24 1

HASNAIN FAHEEM

  • Director
0 2020-06-24 1

MALLEY THOMAS

  • Director
0 2020-06-24 1

STEIN STEVEN H

  • Director
0 2020-06-24 1

SZELA MARY T

  • Director
0 2020-06-24 1

PARKS DIANE L.

  • Director
0 2020-06-24 3

BASTA JAMES CHIEF LEGAL OFFICER

  • Officer
0 2020-03-12 3

MARTELL BRIDGET A ACTING CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-10 2

FLOWERS KIRSTEN CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-01-06 2

GUALBERTO ANTONIO HEAD OF DEVELOPMENT & CMO

  • Officer
339,973 2019-07-10 0

NORTH ANNETTE SVP, GENERAL COUNSEL

  • Officer
0 2019-01-22 0

REN PINGDA SVP CHEMISTRY&PHARMA SCIENCES

  • Officer
0 2019-01-22 0

FARNAM JOHN CHIEF OPERATING OFFICER

  • Officer
0 2019-01-22 0

ECOR1 CAPITAL FUND QUALIFIED, L.P.

  • 10% Owner
4,408,097 2018-12-17 0

HENSON HEIDI CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-24 0

LIU YI CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-01-24 0

KINLEY MATTHEW P SECRETARY, CFO

  • Officer
  • Director
  • 10% Owner
0 2015-03-06 0

VASSILIOU ARGYRIS

  • 10% Owner
No longer subject to file 2015-03-06 0

PAPPAJOHN JOHN PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2015-03-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FORD KATHLEEN - Officer CHIEF OPERATING OFFICER

2020-09-15 19:25:19 -0400 2020-09-15 S 6,250 $29.43 d 0 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

FORD KATHLEEN - Officer CHIEF OPERATING OFFICER

2020-09-15 19:25:19 -0400 2020-09-15 M 6,250 d 237,500 direct yes

FORD KATHLEEN - Officer CHIEF OPERATING OFFICER

2020-09-15 19:25:19 -0400 2020-09-15 M 6,250 $19.43 a 6,250 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

FORD KATHLEEN - Officer CHIEF OPERATING OFFICER

2020-09-15 19:25:19 -0400 2020-09-14 M 6,250 d 243,750 direct yes

FORD KATHLEEN - Officer CHIEF OPERATING OFFICER

2020-09-15 19:25:19 -0400 2020-09-14 S 6,250 $29.43 d 0 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO by araxes pharma llc

2020-09-15 19:22:28 -0400 2020-09-14 S 98,490 $28.82 d 206,736 indirect yes 1.7224 -2.308 3.5136 3 -2.308 6

GRASSO MARC - Officer CFO, CBO

2020-09-15 19:23:53 -0400 2020-09-14 S 10,000 $29.00 d 0 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

FORD KATHLEEN - Officer CHIEF OPERATING OFFICER

2020-09-15 19:25:19 -0400 2020-09-14 M 6,250 $19.43 a 6,250 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

GRASSO MARC - Officer CFO, CBO

2020-09-15 19:23:53 -0400 2020-09-14 M 2,102 d 247,898 direct yes

GRASSO MARC - Officer CFO, CBO

2020-09-15 19:23:53 -0400 2020-09-14 M 2,102 $29.00 a 10,000 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

GRASSO MARC - Officer CFO, CBO

2020-09-15 19:23:53 -0400 2020-09-14 M 7,898 d 105,000 direct yes

GRASSO MARC - Officer CFO, CBO

2020-09-15 19:23:53 -0400 2020-09-14 M 7,898 $29.00 a 7,898 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-09-15 19:22:28 -0400 2020-09-11 M 17,926 $6.15 a 46,022 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO by araxes pharma llc

2020-09-15 19:22:28 -0400 2020-09-11 S 485 $28.00 d 305,226 indirect yes 1.7224 -2.308 3.5136 3 -2.308 6

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-09-15 19:22:28 -0400 2020-09-11 M 17,926 d 157,021 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-09-15 19:22:28 -0400 2020-09-11 S 17,926 $28.00 d 28,096 direct yes 1.7224 -2.308 3.5136 3 -2.308 6

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-09-10 18:05:53 -0400 2020-09-10 M 37,030 $6.15 a 65,126 direct yes 6.428 9.7516 9.7516 6 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-09-10 18:05:53 -0400 2020-09-10 M 37,030 d 174,947 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO by araxes pharma llc

2020-09-10 18:05:53 -0400 2020-09-10 S 1,025 $28.00 d 305,711 indirect yes 6.428 9.7516 9.7516 6 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-09-10 18:05:53 -0400 2020-09-10 S 37,030 $28.00 d 28,096 direct yes 6.428 9.7516 9.7516 6 0.0 1

GRASSO MARC - Officer CFO, CBO

2020-09-10 18:04:44 -0400 2020-09-08 M 10,000 $15.47 a 10,000 direct yes 6.428 9.7516 9.7516 6 0.0 1

GRASSO MARC - Officer CFO, CBO

2020-09-10 18:04:44 -0400 2020-09-08 M 10,000 d 112,898 direct yes

GRASSO MARC - Officer CFO, CBO

2020-09-10 18:04:44 -0400 2020-09-08 S 10,000 $26.00 d 0 direct yes 6.428 9.7516 9.7516 6 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO by araxes pharma llc

2020-09-10 18:05:53 -0400 2020-09-08 S 50,000 $26.00 d 306,736 indirect yes 6.428 9.7516 9.7516 6 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-25 M 215 d 6,945 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-25 S 23,053 $22.37 d 28,096 direct yes 1.0473 0.1257 4.2731 3 0.0 1

GRASSO MARC - Officer CFO, CBO

2020-08-26 18:22:33 -0400 2020-08-25 S 10,000 $23.00 d 0 direct yes 1.0473 0.1257 4.2731 3 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-25 M 22,838 d 211,977 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-25 M 215 $4.80 a 51,149 direct yes 1.0473 0.1257 4.2731 3 0.0 1

GRASSO MARC - Officer CFO, CBO

2020-08-26 18:22:33 -0400 2020-08-25 M 10,000 $15.47 a 10,000 direct yes 1.0473 0.1257 4.2731 3 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-25 M 22,838 $6.15 a 50,934 direct yes 1.0473 0.1257 4.2731 3 0.0 1

GRASSO MARC - Officer CFO, CBO

2020-08-26 18:22:33 -0400 2020-08-25 M 10,000 d 122,898 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-24 S 6,568 $22.04 d 28,096 direct yes 1.0473 0.1257 4.2731 3 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-24 M 6,568 $4.80 a 34,664 direct yes 1.0473 0.1257 4.2731 3 0.0 1

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-26 18:24:13 -0400 2020-08-24 M 6,568 d 7,160 direct yes

DALE STEPHEN - Officer CHIEF MEDICAL OFFICER

2020-08-25 16:25:35 -0400 2020-08-24 A 200,000 a 200,000 direct

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-19 M 11,913 d 13,728 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-19 S 11,913 $22.09 d 28,096 direct yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-19 M 11,913 $4.80 a 40,009 direct yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-18 M 521 $4.80 a 28,617 direct yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-18 M 521 d 25,641 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-18 S 521 $22.00 d 28,096 direct yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO by araxes pharma llc

2020-08-19 18:38:53 -0400 2020-08-17 S 50,000 $22.00 d 356,736 indirect yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-17 S 12,901 $22.00 d 28,096 direct yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO by red fish blue fish revocable trust

2020-08-19 18:38:53 -0400 2020-08-17 G 26,041 a 1,795,017 indirect -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-17 M 12,901 d 26,162 direct yes

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-17 M 12,901 $4.80 a 40,997 direct yes -1.3876 10.407 10.407 6 -1.3876 2

WILSON TROY EDWARD - Director - Officer PRESIDENT AND CEO

2020-08-19 18:38:53 -0400 2020-08-17 G 26,041 d 28,096 direct -1.3876 10.407 10.407 6 -1.3876 2

GRASSO MARC - Officer CFO, CBO

2020-08-11 17:02:47 -0400 2020-08-07 M 7,102 $15.47 a 10,000 direct yes -0.0944 2.5956 35.9132 41.8122 27 -0.9438 3

GRASSO MARC - Officer CFO, CBO

2020-08-11 17:02:47 -0400 2020-08-07 M 7,102 d 132,898 direct yes

GRASSO MARC - Officer CFO, CBO

2020-08-11 17:02:47 -0400 2020-08-07 S 10,000 $20.00 d 0 direct yes -0.0944 2.5956 35.9132 41.8122 27 -0.9438 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Kura Sushi Inc. 0.58% 2019-09-02 UK
Squarepoint Ops LLC Kura Sushi Inc. 0.69% 2019-08-15 UK

Elevate your investments